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Abstract 
Background: The aim of this study was to describe the longevity and causes of mortality in 39 (12 males, 27 females) 
pedigree adult neutered Labrador retrievers with a median age of 6.5 years at the start of the study and kept under 
similar housing and management conditions. Body condition score was maintained between two and four on a 
5-point scale by varying food allowances quarterly. The impact of change in body weight (BW) and body composition 
on longevity was analysed using linear mixed models with random slopes and intercepts.
Results: On 31 July 2014, 10 years after study start, dogs were classified into three lifespan groups: 13 (33 %) 
Expected (≥9 to ≤12.9 years), 15 (39 %) Long (≥13 to ≤15.5 years) and 11 (28 %) Exceptional (≥15.6 years) with 
five still alive. Gender and age at neutering were not associated with longevity (P ≥ 0.06). BW increased similarly for 
all lifespan groups up to age 9, thereafter, from 9 to 13 years, Exceptional dogs gained and Long-lifespan dogs lost 
weight (P = 0.007). Dual-energy x-ray absorptiometer scans revealed that absolute fat mass increase was slower to 
age 13 for Long compared with Expected lifespan dogs (P = 0.003) whilst all groups lost a similar amount of absolute 
lean mass (P > 0.05). Percent fat increase and percent lean loss were slower, whilst the change in fat:lean was smaller, 
in both the Exceptional and Long lifespan compared with Expected dogs to age 13 (P ≤ 0.02). Total bone mineral 
density was significantly lower for Expected compared to Exceptional and Long lifespan dogs (P < 0.04).
Conclusions: This study shows that life-long maintenance of lean body mass and attenuated accumulation of body 
fat were key factors in achieving a longer lifespan. The results suggest that a combination of a high quality plane of 
nutrition with appropriate husbandry and healthcare are important in obtaining a greater than expected proportion 
of Labrador retrievers living well beyond that of the expected breed lifespan: 89.7 % (95 % CI 74.8–96.7 %) dogs were 
alive at 12 years of age and 28.2 % (95 % CI 15.6–45.1 %) reaching an exceptional lifespan of ≥15.6 years.
Keywords: Ageing, Exceptional longevity, Healthspan, Body weight, Sarcopenia, Lean body mass, Body fat mass, 
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Background
For the domesticated dog (Canis lupus familiaris), 
changes observed through ageing can be seen as good 
(e.g. improved obedience), bad (e.g. dental disease) or 
inconsequential (e.g. greying of the muzzle) with respect 
to their viability and survival. Physiological changes that 
may be important biomarkers of ageing in dogs include 
increasing body fat, reducing lean body mass (of which 
lean muscle mass is an important component), peri-
odontal disease, osteoarthritis, reduced renal or cardiac 
function, changes to the endocrine system (including 
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insulin and glycaemic control), cognitive and behavioural 
changes and the development of neoplastic disease [1–4].
The goal for today’s biogerontologists is to extend 
human healthspan, defined as the years in which an 
individual is generally healthy and free from serious dis-
ease, alongside increasing longevity; this goal can also be 
applied to our companion animals [5]. In the domestic 
dog, reported average longevity estimates for all breeds 
combined have varied between 10.0 and 12.0  years, 
depending on the population studied [6–8]. As part of the 
current project, an external panel of veterinary and aca-
demic experts was convened to independently and objec-
tively define an average lifespan for Labrador retrievers 
based on median/mean age at death reported in published 
research and from a proprietary service dog database as 
well as their professional knowledge and/or personal 
experience. Upon review of the body of evidence avail-
able from 1999 to 2013, a consensus was reached that the 
typical lifespan of Labrador retrievers was 12 years of age 
(Table 1). The domesticated dog represents an exceptional 
range of phenotypic morphology with breeds varying in 
weight by two-orders of magnitude [9]. Canine life expec-
tancy and body mass are inversely correlated with size 
explaining 40–44 % of the variance in age at death [8, 9]; 
small breeds typically live much longer than large breeds 
[8, 10–12]. It is not clear what effect neutering has on 
longevity as one study reported that neutering was asso-
ciated with increased longevity for females but not males 
in the UK [6], whilst neutered males outlived entire males 
among US military dogs [13]. Another study has shown 
that neutering was strongly associated with an increase 
in lifespan as well as a decreased risk of death from some 
causes, such as infectious disease, but an increased risk of 
death from others, such as cancer [14]. The discrepancies 
might be related to the age of neutering, however, there is 
a lack of information on this.
With the large disparity in longevity of individual 
dog breeds, the challenge is to understand the biologi-
cal mechanisms that underlie these apparent differ-
ences [15]. The term ‘exceptional longevity’ has be used 
to describe both groups of, and individual, dogs that live 
30 % longer than is expected for their breed’s typical or 
average lifespan [16]. Dogs that live for a longer period 
than their anticipated lifespan appear to demonstrate an 
ability to delay the onset of life-threatening diseases [16–
18]. A previous study of 24 pairs of Labrador retriever 
littermates from 7 litters showed that lifetime calorie 
restriction resulted in a 1.8  year longer median lifespan 
in the ‘Restricted’ group fed 25 % less than the ‘Control’ 
group (P = 0.004) [19].
The longitudinal study reported here is a continua-
tion of efforts to understand the biology of ageing and 
its valuable application to companion dogs. The aim of 
this study was to describe the longevity and causes of 
mortality in a cohort of purebred Labrador retrievers 
kept under similar housing and management conditions. 
Additionally, we wished to evaluate the impact of gender, 




The original study was designed as a clinical trial to test a 
novel energy restriction mimetic in the form of the die-
tary supplement mannoheptulose (MH). MH is a seven-
carbon sugar derived from avocado that acts to reduce 
glycolysis via hexokinase inhibition and has been pro-
posed as a calorie restriction mimetic that delivers anti-
ageing and health promoting benefits of calorie 
restriction without reducing food intake [20, 21]. Initially, 
three groups of dogs were formed from a cohort of 59 
Labrador retrievers after a 15-month acclimatisation 
period from May 2003 to 15 July 2004 (Fig. 1). During the 
acclimatisation period, fasting blood glucose and insulin 
were measured and the dogs were allocated to treatment 
groups using stratified randomisation based on these lev-
els. The study design was approved by the Institutional 
Animal Care and Use Committee (IACUC) of Procter 
and Gamble (P&G) Pet Care (Mason, OH, USA).1 The 
accommodation facility where the dogs were housed, the 
P&G Pet Care Pet Health and Nutrition Center in Lewis-
burg, OH, USA, was accredited by the Association for 
Assessment and Accreditation of Laboratory Animal 
1 The IACUC board had both internal and external board members. The 
external members were represented by a local High School teacher, and a 
local veterinarian from Dayton (OH, USA) with research experience but 
with no affiliation with any type of research institute.
Table 1 Evidence used in  consensus for  ‘Typical’ Labra-
dor retriever lifespan based on  reported ages at  death 
with reference numbers in square brackets
a Canine companions for independence (Santa Rosa, CA, USA)
b Consensus age provided by Jan Bellows, DVM, DAVDC, DABVP, FAVD; Carmen 
M. H. Colitz, DVM, Ph.D., DACVO, Donald Ingram, Ph.D.; Stanley L. Marks, BVSc, 
Ph.D., DACVIM, DACVN; Sherry L. Sanderson, DVM, Ph.D., DACVIM, DACVN; Julia 
Tomlinson, BVSc, Ph.D., DACVS, CCRP, CVSM
Reference material Country #Dogs Median lifespan, years
Assistance dog databasea US 498 12.0
Lawler et al. [2] US 48 ‘Restricted’ group: 13.0
Kealy et al. [19] ‘Control’ group: 11.2
Adams et al. [8] UK 574 12.25
O’ Neill et al. [12] UK 418 12.5
Michell [6] UK 328 12.6
Proschowsky et al. [7] Denmark 199 10.5
Typical lifespan of Labrador retrieversb 12.0
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Care. After the initiation of the clinical trial an independ-
ent International Animal Welfare Advisory Board also 
had input and recommendations principally on the dogs’ 
behaviour and enrichment interventions. This board 
made unannounced visits to the centre and their reports 
were made publically available.2
At the start of the original clinical trial (16 July 2004) 
one group was fed a control diet (n =  20, Table 2), one 
group was fed a study diet matrix (n = 20, Table 2) and 
the third group was fed the same study diet matrix with 
the inclusion of avocado juice extract with a concentra-
tion of <0.10 % as a source of biologically available man-
noheptulose (MH) (n = 19) [22]. As a result of an internal 
business decision, the group of dogs that had been fed 
the control diet were released from the clinical trial and 
entered other feeding programmes in September 2008. 
The feeding of the two other groups continued as before 
with the same allocated study diet with or without MH 
2 International Animal Welfare Advisory Board annual report 2013 is avail-
able at https://www.iams.com/iams-truth/international-advisory-board-
activities.
(Fig. 1). Statistical analysis in June 2013 showed no signif-
icant effect of the diet on longevity detected between the 
19 dogs that received the study diet and MH and the 20 
dogs that were just fed the study diet; therefore, the data 
for these dogs were combined for the longevity analysis 
in this study (Fig. 1). For the remainder of this paper we 
report only on these 39 dogs.
A total of 39 adult, neutered Labrador retrievers con-
sisting of 12 males and 27 females recruited in early to 
mid-adulthood, between the ages of 5.3 and 8.5  years 
(mean age 6.7  years, median 6.5), were included in the 
current longitudinal study. All dogs were acquired from 
private breeders or United States Department of Agricul-
ture-inspected provider. One breeder provided 33 (85 %) 
Labrador retrievers from breeding a total of 12 sires and 
19 dams. For these 33 dogs, the husbandry (feeding and 
kennelling) and medical care (worming and vaccina-
tions) was kept consistent for all the dogs from birth and 
through early adulthood prior to them being recruited 
for the study. Furthermore, these dogs were housed in 
groups of three (one male and two female) in large open 
paddocks that were 15 metres wide by 45 m long covered 
Fig. 1 Flowchart of dogs recruited to the study and included in the analysis. MH mannoheptulose
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with gravel on a concrete base. Covered shelter was avail-
able (the internal housing used straw bedding) from the 
heat/cold and the dogs were all exposed to the same 
natural day/night light cycles. Each dog could hear and 
see their neighbours in the other paddocks. The breeder 
would rotate the males and females according to the 
breeding programme. After recruitment, 38 entire dogs 
were surgically neutered by the supervising veterinar-
ian in 2003 prior to the start of the study period in July 
2004 with only one dog, a male, that had been neutered 
at 4.4  years of age just prior to being recruited into the 
study in 2003. The mean and median age at neutering 
was 5.5 years (range 4.3–7.5 years).
Animal husbandry and veterinary care
Dogs were housed in a kennel system that include indoor 
kennels and outdoor runs. Both the indoor kennels and 
outdoor runs were cleaned and disinfected on a regu-
lar basis, and all had size-appropriate dog toys that were 
cleaned and interchanged regularly to provide environ-
mental enrichment. The temperature of the indoor ken-
nel was kept at approximately 22  °C (range  18–25  °C) 
with a relative humidity of 50  % (range 40–70  %). Air 
flow through the kenneling facility was maintained with 
approximately 15 fresh air changes per hour (range 
10–30). Natural light was provided by large rectangular 
windows that were positioned above each of the individ-
ual indoor kennels and ran on both sides of an open cor-
ridor and for the entire length of the facility. The indoor 
kenneling area also had an automated lighting system that 
controlled the light/dark cycle with 12 h on from approxi-
mately 06.00–18.00 and 12 h off (Invensys system, Inven-
sys Operations Management Company, Plano, TX, USA).
Each dog was groomed every 2  weeks (brushing, nail 
trimming, examination for parasites and skin lesions) and 
bathing was done quarterly. Daily socialisation of all dogs 
took place (20 min) with a qualified animal welfare spe-
cialist and additionally social groups of three to six dogs 
were exercised outdoors daily (30  min minimum) in a 
large gravel lined or grass exercise area. Furthermore, 
compatible groups of dogs had 24-h access to each other 
through their partially covered run that interconnected 
neighbouring kennels.3 Equipment designed to provide 
environmental enrichment (e.g. agility course apparatus, 
wading pools, a variety of dog toys and shaded areas) was 
provided in the large areas.
The preventative healthcare plan for each dog included 
faecal examinations annually for endoparasites alongside 
blood testing for heartworm. Heartworm prevention was 
given monthly (Interceptor®, Novartis Animal Health, 
3 Dogs were housed in indoor kennels either on their own or in pairs. The 
kennels were 122 × 122 cm (single) or 244 × 244 cm (double) and arranged 
either side of an open corridor allowing dogs to see and hear other dogs in 
the group. Suitable bedding (Kuranda Dog Beds, Glen Burnie, Maryland, 
USA) was provided for each dog. The kennels were made from welded 
stainless steel mesh and polycarbonate panels. The floors were epoxy and 
were heated. A two-way door led from each kennel to a partially covered 
outdoor run (365 ×  243  cm) which provided additional access to natural 
light. All runs had concrete flooring and dogs had free access to their run 
throughout the day and night.
Table 2 General ingredient and nutrient composition of the control and study diets
a The control diet was nutritionally complete and balanced and formulated to be representative of a mid-tier adult dog food product
b Study diet was formulated to contain the same nutritional technologies found in the Eukanuba nutritional matrix for senior dogs (Eukanuba® Senior Maintenance 
Dog Food. For the study period reported this product was owned and manufactured by Procter & Gamble, Cincinnati, Ohio, USA)
c Fructo-oligosaccharide
d Sodium hexametaphosphate
e Avocado juice concentrate (<0.10 %) was included in the diet matrix for 19 dogs
f Nutrient composition is actual laboratory analytical results expressed on as-fed basis
g Gross energy
h Ratio of dietary omega-6 fatty acids and omega-3 fatty acids
Ingredient composition Analysis %
Control dieta Study dietb Nutrientf Control Study
Maize Chicken meal Egg product Protein (%) 25.1 24.7
Chicken by-product meal Chicken by-product meal Brewer’s yeast Fat (%) 13.8 15.0
Maize gluten meal Maize FOSc Fibre (%) 2.1 2.1
Soybean meal Sorghum sHMPd Ash (%) 5.3 7.0
Animal fat Barley Linseed Moisture (%) 7.8 7.5
Palatant Chicken fat l-carnitine Vitamin E (IU/kg) 163 328
Minerals Fishmeal Minerals β-carotene (ppm) 2.9 39
Vitamins Palatant Vitamins GEg (kcal/kg) 4716 4695
Beet pulp Othere 6:3 fatty acidsh 19:1 9:1
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US) and flea and tick treatment was given when required 
(Frontline Plus®, Merial) [23]. The vaccination routine 
consisted of adenovirus type 2, distemper, parvovirus, 
parainfluenza, (±  leptospira given according to a health 
risk assessment) and an intranasal vaccine for Bordetella 
administered annually according to manufacturer’s rec-
ommendations (Fort Dodge Duramune Max 5/4L®; Sher-
ing-Plough Intra-Trac II ®Bordetella Vaccine). 
Vaccination against Rabies was given every three years 
(Fort Dodge RabVac® 3TF). Oral health was evaluated 
with dental examinations performed every 6  months; 
standard dental prophylaxis/treatment (e.g. extractions, 
descaling and polishing under anaesthesia) was per-
formed for each dog when necessary as recommended by 
the attending veterinarian. Standard physical examina-
tions were undertaken annually and blood samples col-
lected every 6  months for routine clinical assessment. 
Clinical parameters measured included complete blood 
cell counts, serum biochemistry and thyroid function. 
Aside from the regular veterinary examinations, each dog 
was monitored daily by their animal welfare specialist 
and the animal husbandry staff, and any health related 
concerns (e.g. medical, orthopaedic, oncologic) were 
brought to the attention of the attending healthcare staff. 
At this point the healthcare staff would initiate a regular 
quality of life assessment to monitor the dog’s health and 
to assess if it remained stable or declined.4 The case was 
then discussed by a group that was blinded to the identity 
of the dog. Decisions about medications and end-of-life 
issues were made by the group based on whether the 
quality of life was declining and the dog’s overall well-
being was compromised (see footnote 4). The group con-
sisted of the study director, several veterinarians within 
other business units of the company as well as other vet-
erinarians from the pet care unit. The on-site attending 
veterinarian also was authorised to make an end-of-life 
decision if there was a rapid deterioration in any dog’s 
health.
Diet and feeding
From May 2003 until the start of the study on 16 July 
2004 all dogs spent 1 year on a nutritionally complete and 
balanced control diet which was formulated to be 
4 Assessments were conducted by animal welfare specialists, animal hus-
bandry staff and healthcare staff (attending veterinarian, veterinary nurses) 
to assess quality of life using a 10-point Likert scale ratings to assess food/
water intake (hunger/thirst), pain/discomfort, mobility, hygiene, happiness 
and number of “good days”. When the dog was having more “bad days” than 
“good days” then the attending veterinarian convened a panel to discuss an 
end-of-life decision; original concept, Oncology Outlook, by Dr. Alice Vil-
lalobos, Quality of Life Scale Helps Make Final Call, VPN, 09/2004; scale 
format created for author’s book, Canine and Feline Geriatric Oncology: 
Honouring the Human-Animal Bond, Blackwell Publishing, 2007. Revised 
for the International Veterinary Association of Pain Management (IVAPM) 
2011 Palliative Care and Hospice Guidelines.
representative of a mid-tier adult dog food (Control diet, 
Table  2). This was to help acclimatise the dogs to their 
environment and to help adjust their body weight and 
body condition score so that they entered the study in 
2004 with a body condition score (BCS) between two and 
four, based on a 5-point BCS [24]. This adaptation period 
also helped establish the individual food allowance 
required to maintain body weight with a BCS between 
two and four. Following this year of acclimation, the 39 
dogs were transitioned onto a study diet formulated with 
the same nutritional technologies shown to help support 
the health and well-being of both adult and senior dogs 
(Study diet, Table 2). This dietary matrix was created to 
comprise the same nutritional components found in 
Eukanuba® Senior Maintenance5 for large breed dogs but 
with a slightly lower protein (24.7 % ‘as fed’) and slightly 
higher fat (15 % ‘as fed’) level.
BCS was assessed by trained staff on a quarterly basis 
both during the adaptation year and during the study 
using a five-point scale. A score of 3 was considered ideal. 
A dog’s daily food allowance was changed if the quarterly 
BCS was not between the 2–4 range to avoid the extremes 
of thinness (BCS  =  1) or obesity (BCS  =  5) conditions. 
The maximum allowable change to an individual dog’s 
daily food allowance was ±50 g and this food amount was 
maintained until the next quarterly BCS assessment. The 
daily food allowance could also be changed by the super-
vising veterinarian for medical purposes.
The daily ration of food was weighed for each dog, 
divided into two equal portions, and offered in stainless 
steel food bowls inserted into rings located at the front of 
each indoor pen at 07:30 and 14:30 each day. Dogs were 
separated for feeding. Each dog was allowed 30  min to 
consume their food and food intake was recorded daily. 
Fresh water was constantly available using automatic 
adjustable water bowls mounted on the side of each 
housing unit.
Body weight and composition
Body weight was measured every 2 weeks, BCS was evalu-
ated quarterly and whole-body composition measures were 
obtained prior to the start of the study and then annually 
using a Dual-Energy X-ray Absorptiometer (DEXA scan) 
(Model Delphi-A, Serial No. 70852; Bedford, MA). For 
the DEXA scan, dogs were fasted for a minimum of 12  h 
prior to being sedated using a pre-anaesthetic combina-
tion of Acepromazine (PromAce® Injectable, Fort Dodge, 
Fort Dodge, Iowa; 0.55 mg/kg intramuscular injection) and 
Atropine Sulfate (Med-Pharmex, Pomona, CA; 0.04  mg/
kg subcutaneous injection). Dogs were then anaesthetised 
5 Eukanuba® Senior Maintenance Dog Food. For the study period reported 
this product was owned and manufactured by Procter & Gamble, Cincin-
nati, Ohio, USA.
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with Propofol administered via a secured intravenous cath-
eter (Propoflo®, Abbot Labs, Chicago, IL; 7  mg/kg), intu-
bated with an endotracheal tube and delivered 100 % oxygen. 
Routine anaesthetic monitoring was performed. Dogs were 
positioned in sternal recumbency with hind limbs extended 
caudally. A calibration was completed prior to each DEXA 
scan and measurements were taken using the whole body 
scanner (single-beam mode). After the scans, anaesthesia 
was discontinued and oxygen was continued for several min-
utes. Dogs were moved to a recovery cage and the endotra-
cheal tube was removed once the swallowing reflex was 
regained. Whole-body measures obtained from the DEXA 
scans included total bone mineral density (BMD in grams), 
total bone mineral content (BMC in grams), total body mass 
(g), total fat mass (g), total lean mass (g), % body fat, % body 
lean and fat to lean ratio (determined as total fat mass/total 
lean mass).
Statistical analysis
Dogs were classified into three groups derived from ter-
tiles of lifespan data as of 31 March 2014: Expected’ 
when they experienced a lifespan of ≥9 to ≤12.9 years, 
‘Long’ when they experienced a lifespan between  ≥13 
and  ≤15.5  years and ‘Exceptional’ when they 
achieved ≥15.6 years and beyond. The value of 15.6 for 
the Exceptional lifespan group is 30  % longer than the 
12-year typical lifespan of the breed determined by the 
consensus group (Table  1) [16]. Average body weights 
and ages among the three longevity groups at the start of 
the longitudinal study were compared using analysis of 
variance with post hoc pairwise comparisons. Cross-
tabulations and Chi square or Fishers Exact tests were 
used to compare proportions of dogs within various 
groups. Survival analysis, using Kaplan–Meier (KM) and 
Cox proportional hazards regression (Cox) models, was 
performed to examine the effect of potential predictors 
on time to death. Monthly body weights up to December 
2013 and annual body composition data up to 13 years 
of age were analysed using linear mixed models with 
random effects for slopes and intercepts and a fixed 
effect for the lifespan grouping variable. The models 
allowed an intercept and slope to be estimated for each 
dog with the assumption that each endpoint response 
for a dog had a linear trajectory across age. Body weight 
against age presented by longevity category in a polyno-
mial smooth plot did not show a linear trend but a curve 
that follows an inverted U shape (Fig.  2); therefore, a 
random coefficient model was used to compare the 
slopes as a measure of body weight change (kg/dog/year) 
for three groups: up to 9 years, 9–13 years and >13 years 
of age. An age cut-off point of 13 years was chosen for 
statistical analysis because all three lifespan groups were 
fully represented up to age 13. Statistical analysis was 
performed using commercial software.6 The level of sig-
nificance for all statistical tests was set at P < 0.05.
Results
Longevity and cause of death
As of July 2004, the dogs that were subsequently classi-
fied as experiencing an Exceptional lifespan were sig-
nificantly older than the other dogs (P = 0.01) and there 
were no significant differences in body weight (P = 0.36, 
Table 3). The median time spent in this longitudinal study 
(from 16 July 2004 to death or the censor date for lon-
gevity estimation) by the 39 dogs was 7.43 years and this 
ranged from 2.54 to 10.04 years. As of the censor date of 
31st of July 2014, the distribution of dogs based on lifes-
pan groups was: Expected lifespan (n =  13), Long lifes-
pan (n = 15) and Exceptional lifespan (n = 11 including 5 
dogs that remained alive with a median age of 17.1 years, 
Table 4; Fig. 3). A total of 35 dogs (89.7, 95 % CI 75–97 %) 
were alive at 12 years of age and 11 dogs (28.2, 95 % CI 
15.6–45.1 %) attained exceptional longevity, reaching or 
6 Statistical software: SAS version 9.3 (SAS Institute, 2011, Cary, NC, USA), 
Statistix version 10 (Analytical Software, 2013, Tallahassee, FL), SPSS ver-
sion 22 (IBM SPSS, 2013, Chicago, IL, USA) and Stata version 13.1 (Stata-



















Fig. 2 Polynomial smooth plots of average body weight (lines) with 
95% confidence intervals (CI, gray shaded areas) by age for each lon-
gevity group of dogs. The starting point for each line is the average 
body weight for those dogs which were in the acclimatisation period 
at that age on 01 July 2004 just before the study started. The end 
point for each line is the average body weight for those dogs which 
died or were censored (N = 5 in the Exceptional group) at that age at 
the censor date of 31 July 2014. These plots show that the Expected 
dogs (blue line) started at a low weight, then put on about 1 kg/year 
until reaching a peak at 11 years of age and this was followed by a 
decline of ~1.7 kg in 2 years. The Long-lived dogs (green line) started 
at a higher weight, then stayed at a rather stable weight before show-
ing an increased weight over to reach a peak at 10 years of age and 
then the weight declined at ~1 kg/year. The Exceptionally long-lived 
dogs (gray) started at the lowest weight (but at an older age) and 
they put on weight gradually to reach a peak at 12 years of age, then 
slowly declined to reach a low point at 16 years before putting on 
some weight again
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exceeding 15.6 years of age. The five exceptionally long-
lived dogs that remained alive at the censor date were 
considered to be 3–4  years younger than their chrono-
logical age, based on overall condition, activity level 
and interactive behaviour as observed by several inde-
pendent veterinarians and Labrador retriever enthu-
siasts who interacted with these dogs in June 2014. For 
the 34 dogs that passed away during the study the age at 
death ranged from 9.7 to 16.9 years with a median age of 
death of 13.6 years. Each of the lifespan groups had sig-
nificantly different median survival time (MST) based on 
KM survival analysis (Table 4; Fig. 3). A larger proportion 
of female dogs reached an Exceptional age (female:male 
ratio = 10:1) compared with the Expected (7:6) and Long 
(10:5) lifespan groups although this was not a statisti-
cally significant difference (P = 0.1). Gender was not sig-
nificantly associated with survival time (KM P = 0.06) or 
risk of death (Cox P =  0.07) and there was no effect of 
the age of neutering on the risk of death for females (Cox 
P = 0.2) or males (Cox P = 0.7).
Cancer was the reason for euthanasia for 13 dogs 
(38  %) with 20 dogs (59  %) undergoing euthanasia for 
other reasons and one dog died overnight (enteritis, 
colitis and protein-losing enteropathy were found on 
post-mortem examination) (Table 5). Of the 13 dogs that 
underwent euthanasia as a result of cancer: 54 % of these 
dogs lived to an Expected age, 31  % were in the Long 
group and 15 % in the Exceptional group although these 
proportions were not significantly different (P  =  0.3, 
Table 5).
Body weight and composition changes
From the start of the study to age 9, body weight increased 
for all three lifespan groups (Fig. 2) but the changes over 
this period were not significantly different (Table  6). In 
contrast, there was a significant change in body weight 
(kg/dog/year) during the span of 9–13  years as Excep-
tional dogs increased body weight while the Long lifespan 
dogs lost weight (+0.53 vs. −0.91  kg/dog/year respec-
tively, P  =  0.007). The Expected lifespan dogs also lost 
weight during this period (−0.15) but the loss was not sig-
nificantly different from the Exceptional or Long lifespan 
groups. After age 13, dogs in the Exceptional and Long 
groups both lost a comparable amount of body weight. 
The polynomial plot in Fig. 2 reveals that the dogs in the 
Exceptional group had a lower peak in body weight and 
this peak occurred at a later age compared to the dogs in 
the Expected and Long lived groups.
The 39 dogs underwent between 3 and 10 DEXA scans 
during the study period with a median of seven scans 
per dog. Total fat mass (g/dog/year) increased in all lifes-
pan groups to age 13 but the increase was significantly 
slower only for the Long lifespan dogs when compared 
with Expected dogs which accumulated fat at 3.1 times 
the rate over this time period (slopes of +320 vs. +1000, 
P = 0.003 Table 7). In contrast, all groups lost a similar 
amount of total lean mass (g/dog/year) through age 13 
ranging from −593 (Expected), −461 (Long) to −269 
(Exceptional) (P > 0.05). Percent body fat increased sig-
nificantly more slowly to age 13 in both the Exceptional 
and Long-lived dogs compared with Expected dogs (1.55 
and 1.25 vs. 2.69, respectively, P = 0.02 and P = 0.002). 
Congruently, the percentage loss of lean mass through 
age 13 was significantly slower for dogs of Exceptional 
and Long lifespans when compared with those having an 
Expected lifespan (−1.58 and −1.31 vs. −2.69, respec-
tively, P = 0.02 and P = 0.002). Similarly, the change in 
the fat to lean ratio to age 13 was significantly greater in 
the Expected dogs versus both the Exceptional and Long 
lived dogs (P = 0.02 and P = 0.002). Total bone mineral 
density (BMD) was significantly lower for Expected com-
pared to Exceptional and Long (P < 0.04). There were no 
statistically significant differences among the lifespan 
groups for changes in total bone mineral content (BMC) 
(P  =  0.2). There were no statistically significant differ-
ences in BCS slopes over time among the three lifespan 
groups (data not shown).
Discussion
The results of this longitudinal study show that a greater 
than expected proportion of Labrador retrievers lived 
well beyond that of the expected breed lifespan as nearly 
90 % (n = 35) of the dogs met or surpassed the consen-
sus average life expectancy for the breed of 12 years and 
28 % (n = 11) went on to achieve Exceptional longevity 
(≥15.6  years). In spite of being 16 and 17  years of age, 
Table 3 Mean ages and body weights for the three longevity groups of dogs in July 2004
Means among longevity groups were compared using analysis of variance with post hoc pairwise comparisons; mean body weights were not significantly different 
(P = 0.36) whilst means within the age column that share an asterisk (*) or a hash (#) were significantly different (P = 0.01)
N number of dogs, SD standard deviation, Min–max range from minimum to maximum values
Longevity category N Mean body weight 
(kg)
SD Min–max Mean age (years) SD Min–max
Expected (≥9 to ≤12.9 years) 13 29.4 4.6 20.2–37.40 6.5* 0.6 5.3–7.6
Long (≥13 to ≤15.5 years) 15 29.4 4.3 21.1–41.4 6.4# 0.9 5.4–7.9
Exceptional (≥15.6 years) 11 26.8 3.7 19.2–33.1 7.4*# 0.8 6.0–8.5
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the five dogs remaining alive at the end of the study con-
tinued to be full of life, active, social and highly engaged 
with their animal welfare specialists and social groups 
according to the independent veterinarians and Labra-
dor retriever enthusiasts who interacted with these dogs 
in June 2014. This supports our findings that an increase 
in healthspan was present in this study population. 
These findings are similar to those reported in an earlier 
longitudinal study of the effect of calorie restriction in 
Labrador retrievers where the ‘Restricted’ group experi-
enced a median lifespan of 13.0 years with a maximum 
lifespan of 14.5  years compared to 11.2 and 13.2  years, 
respectively, for the ‘Control’ group [2, 19, 25, 26]. It may 
therefore be suggested that identifying the appropriate 
calorie balance (i.e. calorie intake that matches calorie 
expenditure) in order to reach and maintain an ideal 
BCS throughout the lifespan of Labrador retrievers and 
adhering to this feeding level may be essential in achiev-
ing a long, healthy life.
There was a slower loss of total and significantly 
slower loss of percentage lean body mass in the Excep-
tional group versus the Expected group together with a 
slower increase in total body fat and a significantly slower 
increase in percentage body fat and a significantly lower 
change in fat to lean ratio. This is similar to the findings 
of another study in which body composition was meas-
ured from 6 years of age where the mean total lean mass 
was significantly greater in the ‘Control’ group compared 
to the ‘Restricted’ group; additionally, there was a pro-
gressive decline in total lean mass after 9 years of age in 
the ‘Control’ group but not in the ‘Restricted’ group until 
after 11 years of age [2, 19]. Furthermore, although mean 
percentage lean mass decreased significantly in both 
groups from 6 to 12  years of age it was always signifi-
cantly higher among the ‘Restricted’ dogs than the ‘Con-
trol’ dogs [19]. Mean total and percentage body fat mass 
increased significantly in both groups from 6 to 12 years 
of age and was always significantly higher in the ‘Control’ 
group. There was no correlation between total lean and 
fat mass in the ‘Restricted’ group and this may suggest 
underlying processes that drive the beneficial longev-
ity response in these dogs may be multiple and driven 
independently [2]. Somewhat paradoxically, the dogs in 
the Long lifespan group of the current study lost weight 
between the ages of 9 and 13 years whilst the Exceptional 
lifespan dogs maintained or slightly gained weight dur-
ing this time period. Body mass and body composition 
are related to an individual dog’s size and they may also 
independently influence the rate of ageing and longevity. 
The risks of an increase in the incidence and severity of 
chronic disease associated with high body fat has been 
reported in other studies [27–29]. In adult nonhuman 
primates, lower morbidity rates also have been reported 
in studies comparing calorie-restriction versus ad lib 
Table 4 Number of Labrador retrievers, age at death/censor date and median survival time with 95 % CIs
Within each column (mean, median, MST), values which share an asterisk (*) are each significantly different from one another (P < 0.0001) by parametric and non-
parametric analysis of variance for age at death/censor date and by Kaplan–Meier survival analysis; values within a column with no asterisk were not compared
CI confidence interval, NE not estimated using Statistix commercial software
a July 31, 2014
Longevity category Descriptive statistics for age in years at death/censor datea MST (95 % CI) in years 
from Kaplan–Meier analysis
N (%) Mean (SD) Median (min–max)
Expected ≥9 to ≤12.9 Deceased 13 (33 %) 12.08* (1.04) 12.58* (9.68–12.95) 12.44* (11.70–12.80)
Long ≥13 to ≤15.5 Deceased 15 (39 %) 14.21* (0.58) 14.15* (13.18–15.19) 14.08* (13.63–14.72)
Exceptional ≥15.6 Deceased 6 15.98 (0.49) 15.80 (15.68–16.96)
Alivea 5 16.82 (0.65) 17.13 (16.04–17.50)
Sub-total 11 (28 %) 16.36* (0.69) 16.04* (15.68–17.50) 16.47* (15.76–NE)
Overall Overall 39 (100 %) 14.11 (1.86) 14.01 (9.68–17.50) 14.01 (13.18–14.77)






















Survival time in years
Fig. 3 Kaplan–Meier survival plot for 39 Labrador retrievers in three 
lifespan groups. Expected (blue): 13 dogs; Long (green): 15 dogs; and 
Exceptional (gray): six deceased and five dogs remaining alive as of 
the July 31, 2014 censor date
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feeding. In the calorie-restriction primates (fed 30–40 % 
less calories than their ad lib pair mate) the body fat con-
tent was within the normal range of 10–22 % [30]. Typi-
cally, the body fat in ad lib fed primates can range from 
17–44  % [31]. This calorie-restriction induced preven-
tion of morbidity does not therefore require excessive 
leanness.
A comparison between the dogs in the current study 
and those from the calorie restricted study [2, 19, 25] 
shows that energy intake per unit of body weight kcal/
kg/day for the ‘Restricted’ group (≈46.5) was very close 
to the 46.2–48  kcal/kg/day of dogs in the current study 
(Table  8). Therefore, on an energy intake basis, we 
can consider these groups of dogs to be similar. This is 
reflected by the ‘Restricted’ group having a BCS in the 
ideal range of 4–6 on a 9-point scale from 6 to 12 years 
of age. However, the oldest dog in the ‘Restricted’ group 
died at 14.5  years of age whilst a female in the current 
study was still alive on July 31, 2014 at 17.5 years of age. 
We can only speculate why we had dogs showing much 
Table 5 Cause of death for 34 dogs by gender and lifespan category as of 31 July 2014
33 dogs underwent euthanasia due to deteriorating quality of life and one dog found dead in the morningb 
a Histopathology revealed inflammatory process in kidney indicating chronic infection (asymptomatic)
b Post-mortem examination revealed enteritis and colitis with evidence of protein-losing enteropathy and mild multifocal glomerulosclerosis
c Histopathology revealed inflammatory changes in gastro-intestinal tract
Cancer Expected: ≥9 to ≤12.9 years Long: ≥13 to ≤15.5 years Exceptional: ≥15.6 years Total
 Female 3 = Haemangiosarcoma
 unspecified type/location
Haemangiosarcoma
 splenic with metastasis
Lymphosarcoma








 Male 4 = Haemangiosarcoma
 prostate/bladder
Prostatic cancer
Mast cell tumour metastasis
Urinary tract cancer—TCC
1 = Urinary tract cancer
 bladder
0 5
Sub-total 7 (54 %) 4 (27 %) 2 (33 %) 13 (38 %)
Other
 Female 4 = Intervertebral disc disease
Mega-oesophagus




7 = Gastric dilatation volvulus






4 = Osteoarthritis (2)
Quality of life (2)
15
 Male 2 = Osteoarthritis 4 = Found deceased in kennel (enteri-
tis, colitis and PLE)b
Gastro-intestinal inflammationc
Chronic kidney disease (end stage)
Myocardial fibrosis
0 6
Sub-total 6 (46 %) 11 (73 %) 4 (67 %) 21 (62 %)
Total 13 (100 %) 15 (100 %) 6 (100 %) 34 (100 %)
Table 6 Body weight change (slope) for three age categories of Labrador retrievers up to death/censor date 31 July 2014
Means within the 9–13 years column which share an asterisk (*) are significantly different (P = 0.007); none of the means within the other two columns (up to 9 years, 
after 13 years) show any significant differences among them (P > 0.05)
N number of dogs, SEM standard error of the mean
Longevity category Up to 9 years 9–13 years After 13 years
N Mean (in kg/dog/year) SEM N Mean (in kg/dog/year) SEM N Mean (in kg/dog/year) SEM
Expected (≥9 to ≤12.9 years) 13 0.59 0.3 13 −0.15 0.31 N/A
Long (≥13 to ≤15.5 years) 15 0.52 0.28 15 −0.91* 0.28 15 −1.41 0.68
Exceptional (>15.6 years) 11 0.4 0.36 11 0.53* 0.32 11 −1.31 0.74
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longer lifespan than the dogs in the other study despite 
being on the same calorie intake and BCS level. The 
detailed data on body composition is providing a poten-
tial in investigating reasons related to increased health-
span beyond the BCS and calorie intake. As well, the 
overall median lifespan was 13.0  years for the 48 dogs 
in the calorie restricted study whilst the median age (at 
death and for those still alive) was 14.01 years for the 39 
dogs reported here. One important difference between 
the Labradors reported in this study and those in the 
calorie restricted study is that all the dogs in the present 
study were kept at a BCS between two and four through-
out the study. The classic calorie restriction model used 
to examine the effects of feeding on the ageing process is 
often described as one of undernutrition without malnu-
trition. This usually involves control animals that are fed 
ad libitum (free choice with no or little restriction) as in 
the studies by Kealy, Lawler et al. [2, 19, 25, 26] and com-
paring these to animals fed a set restricted number of cal-
ories (i.e. not free choice). However, the energy intake of 
such ‘control fed’ animals often significantly exceeds the 
amount expended, resulting in a substantial gain in body 
weight, or positive energy balance, which is often associ-
ated with the early onset of disease [19, 32–34]. As the 
majority of dogs were recruited from the same breeder, 
the variation in environmental exposures among these 
dogs is reduced even if those dogs did not share the exact 
same habitat (for example due to temporal differences 
among litters). With regards to the genetic background, 
the dogs in this study were not as closely related as the 
dogs in the restricted feeding study. We recognise that 
the longevity effect seen in this study could be partly or 
wholly explained by the relatedness/line breeding of the 
dogs. However, dogs from the one breeder were found 
in all three longevity categories so although there might 
be a genetic predisposition for longevity, not all dogs 
expressed this characteristic.
As the mean body weights for the three longevity 
groups at the start of the study were not significantly 
different, we suggest that body weight alone, and par-
ticularly during middle age (5–8 years) is not predictive 
of longevity. The association over time between changes 
Table 7 Results of  linear mixed regression for  average changes in  body composition determined by  DEXA scans per-
formed annually up to 13 years of age
Means within a row that share an asterisk (*) or a hash (#) are significantly different (P < 0.05); means within a row with no asterisk or hash are not significantly different 
(P > 0.05)
DEXA Dual-energy x-ray absorptiometer scans obtained using DXA Model Delphi-A, Serial No. 70852; Bedford, MA, USA
N number
a  Means and standard errors of the mean (SEM) for changes in body composition (slope) as g/dog/year or %/dog/year up to 13 years
b  The fat to lean ratio was determined as total fat mass (g)/total lean mass (g)
DEXA variable Longevity category
Expected (≥9 to ≤12.9 years) Long (≥13 to ≤15.5 years) Exceptional (≥15.6 years)
N Meana SEMb N Meana SEMb N Meana SEMb
Total fat mass (g) 13 1000* 165 15 320* 152 11 625 170
Total lean mass (g) 13 −593 127 15 −461 80 11 −269 165
Body fat (%) 13 2.69*# 0.35 15 1.25* 0.31 11 1.55# 0.36
Body lean (%) 13 −2.69*# 0.33 15 −1.31* 0.29 11 −1.58# 0.34
Fat:Leanb 13 0.06*# 0.01 15 0.03* 0.01 11 0.04# 0.01
Total BMC (g) 13 10 3.2 15 18 3.1 11 16.6 3.2
Total BMD (g) 13 0.0061*# 0.0022 15 0.0123* 0.0019 11 0.0131# 0.0024
Table 8 Energy intake of Labrador retrievers in the current study and a previous calorie restricted study
a Group of Labrador retrievers fed 25 % less than their ‘Control’ fed pair; Kealy et al. [19, 25] and Lawler et al. [2]
b Metabolic energy of the test diet fed was 3669 kcal/kg based on a Modified Atwater calculation
Average daily intake of energyb Current study Calorie ‘restricted’ groupa
Expected Long Exceptional
MJ/day 5.88 5.84 5.56 5.15
kcal/day 1405 1397 1329 1230
Energy intake kcal/kg/day 46.2 46.2 48 ≈46.5
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in different body mass components and health may pro-
vide key insights into future recommendations on how 
to manage our ageing dogs more successfully to achieve 
an improved healthspan. One key body mass compo-
nent is skeletal muscle. A number of age-related changes 
may contribute to the gradual age-related loss of skeletal 
muscle which is reported in humans and dogs [35]. This 
loss of lean body mass in the absence of disease is termed 
‘sarcopenia’ and it is important to differentiate this from 
‘cachexia’ which is the loss of lean body mass with disease 
[36]. Sarcopenia is defined in humans as “a syndrome 
characterised by progressive and generalised loss of skel-
etal muscle mass and strength with a risk of adverse out-
comes such as physical disability, poor quality of life and 
death” [37]. Sarcopenia in humans usually begins early in 
life and between the ages of 20 and 60 years there is on 
average a loss of 40 % of lean muscle mass [38]. In sarco-
penia, the loss of lean body mass often is accompanied 
by an increase in fat mass so the total weight may not 
change (or may even increase), thus masking the sarcope-
nia [36]. Previous studies in dogs have shown that a high 
percentage of lean mass was associated with a protective 
effect from death whilst declining grams of lean body 
mass as well as a high percentage and absolute (grams) 
of fat mass predicted death [26]. The present study is 
the first published study to show an association between 
a slower rate of loss of lean body mass and exceptional 
longevity in dogs. The polynomial smooth plot (Fig.  2) 
revealed that the oldest dogs in the Exceptional group 
had an initial peak in body weight at 12 years of age and 
then re-gained weight after 16  years of age following a 
period of weight loss. This weight re-gain could represent 
a longevity advantage for these ‘oldest of the old’ dogs, 
however due to the small number of dogs included in 
this category, results need to be interpreted with caution. 
Further evaluation of what contributes to this late weight 
gain (e.g. slower loss of lean body mass combined with 
an increase in fat mass) could provide information on 
preferable body composition changes that would confer a 
longevity advantage to dogs.
Among human centenarians, women outlive men by 
four to one and, like women, female Rottweilers were 
more likely to achieve exceptional longevity (age at 
death ≥13 years) than males of this breed in a large retro-
spective study that examined the effect of ovary exposure 
up to 8  years of age [16]. However, this survival advan-
tage was lost if the dogs underwent ovariectomy dur-
ing the first 4 years of life. In females that retained their 
ovaries for more than 4 years, the likelihood of reaching 
exceptional longevity increased to more than three times 
that of males. Additional data from female Rottweiler 
dogs revealed that the number of years of ovary exposure 
was associated with exceptional longevity [39]. Females 
with the longest ovary exposure (6.1–8.0 years) were 3.2 
times more likely to reach exceptional longevity than 
females spayed during the first 2 years of life (P = 0.002). 
Furthermore, there was no evidence of a female’s physi-
ological investment in offspring (number of litters, total 
number of pups, age at first reproduction, mean inter-
birth interval, age at last reproduction) being associated 
with a reduced longevity [18]. These findings suggest 
that the ovaries participate in functions beyond repro-
duction which may include a role in the orchestration of 
exceptional longevity. Contrastingly, there was no effect 
of gender or the age at neutering on the risk of death for 
the dogs in the present study. The discrepancies between 
the Rottweiler study and our study may be related to 
the small sample producing a low statistical power as 
supported by the finding that whilst female Labrador 
retrievers tended to live longer than males, there was no 
statistically significant effect of gender on risk of death 
and age at death.
Whilst these dogs were not housed in a natural pet 
environment (such as in a household with human ‘com-
panions’), they were housed in compatible social groups 
and also had regular daily interaction with people much 
as a household pet might. Although there may be large 
differences between the structured management of the 
study dogs and typical household/family dogs, the benefit 
of keeping the study dogs under very similar conditions 
throughout the study removes the effect of many poten-
tial confounding variables that could change over time in 
a household environment. A study of family-owned dogs 
would require a much larger sample size when investi-
gating associations between risk factors and outcomes. 
Such a large sample would not only be very expensive 
but is likely to suffer from participants leaving the study 
due to the long time commitment. The decision not to 
treat any cancer diagnosis with chemotherapy or radio-
therapy, and to manage the dog through palliative care 
with other medications, was due to an ethical position 
by the company as well as representing a choice that dog 
owners might make if their own pet was diagnosed with 
cancer, particularly at an older age. All dogs with cancer 
and other chronic medical conditions had quality of life 
assessments initiated at the time of diagnosis to ensure 
that their health and well-being was managed ethically 
and appropriately (see footnote 4). Other medical issues 
such as ear and skin conditions were managed by the 
healthcare staff under veterinary supervision. The radia-
tion risk associated with the annual general anaesthetic 
for the DEXA scans was assumed to be negligible based 
on published information about DEXA scans in people 
[40].
Conducting breed-specific longevity studies is both 
a strength and a limitation; initially, it may seem to 
Page 12 of 14Adams et al. Acta Vet Scand  (2016) 58:29 
potentially limit the understanding of healthy ageing. 
For instance, it has been shown that the median lifespan 
of crossbreds is greater than purebred dogs [12, 41] and 
that even within a set weight range of breeds there can 
be differences in the median age of death [8, 12]. How-
ever, by evaluating a single breed, rather than multiple 
breeds, then the influence on longevity by factors such 
as obesity and ovary exposure, as well as the age at onset 
of specific age-related disease might become clearer [42] 
as variation on other factors is reduced. When multiple 
breeds are evaluated together, such associations may 
be disguised or distorted. A limitation of this study is 
the absence of a control group fed a different diet as a 
result of a business decision in 2008 to discontinue the 
third study group. However, the strength of the cohort 
approach taken in this longitudinal study is that it allows 
further work using survival analysis to examine the 
effects of the time-varying measurements on longevity 
and development of disease. Whilst this was not a birth 
cohort and the results may be confounded by early life 
experiences, previous work has shown that deaths in Lab-
rador retrievers less than 6 years of age were mostly due 
to trauma [43] and in the aforementioned calorie restric-
tion study only two dogs from the original 48 died before 
6 years of age [26]. There are many factors that may have 
contributed to the ability of these dogs to exceed a typical 
lifespan and reach exceptional longevity. These include 
genetics, husbandry, preventative healthcare, socialisa-
tion, housing and environmental enrichment. Longevity 
is generally accepted as having a heritability of approxi-
mately 25–30 %, with the effect of the environment hav-
ing a much larger influence [44]. Nutrition is part of this 
environmental influence and therefore has a potentially 
significant role to play in longevity. Many of the probable 
environmental influences that could impact successful 
ageing and longevity were maintained as constant as pos-
sible for all the dogs in the current study. The nutritional 
matrix fed to all dogs incorporated key nutritional com-
ponents that have been shown to benefit canine health 
and well-being based on results of short-term research 
studies. This longitudinal study is the first to incorporate 
all of these nutritional components into the same dietary 
matrix consistently fed over an extended period of time. 
As dogs pass through the ageing process their nutritional 
requirements change reflecting a normal response to age-
related metabolic and physiologic responses. The dietary 
matrix fed was designed to address recognised changes 
that take place as dogs pass from adulthood into their 
senior years. The test diet (Table  2) was a matrix based 
on animal protein ingredients, balanced omega-6/3 
fatty acids with a blend of low glycaemic index carbohy-
drates alongside L-carnitine. Antioxidants vitamin E and 
beta-carotene, the moderately fermentable beet pulp 
and the prebiotic fructooligosaccharide were also incor-
porated. Finally, the outside of the dry food was coated 
with sodium hexametaphosphate to help with reduction 
of tartar build-up. It is likely that there are many dietary 
factors including total energy intake relative to energy 
needs, specific nutrients and other non-nutrient bioac-
tive substances that, individually or collectively, influ-
ence the ageing process.
Highly successful ageing can be considered as being 
robust in an age-specific way and which translates into 
being resilient to disease, including cancer. For humans 
it has been hypothesised that centenarians either mark-
edly delay or escape age-associated morbidity such as 
heart disease, stroke, diabetes, cancer, and Alzheimer’s 
disease [45]. Consistent with this idea is the proposition 
from James Fries, known as the compression of morbid-
ity hypothesis which states that individuals who reach the 
limits of human lifespan compress the onset and duration 
of illnesses toward the end of life [46, 47]. This hypoth-
esis predicts that, in order to achieve their extreme old 
age, centenarians markedly delay or even escape dis-
eases that would otherwise be lethal at younger ages. A 
retrospective cohort study of 424 human centenarians 
examining the ages of onset for 10 age-associated dis-
eases and excluding cognitive impairment, found that 
the centenarians fitted into three morbidity profiles; 
Survivors, Delayers, and Escapers [48]. Survivors (38  % 
of study population) had a diagnosis of an age-associ-
ated illness prior to the age of 80, Delayers (43 %) were 
individuals who delayed the onset of age-associated ill-
ness until at least the age of 80 and Escapers (19 %) were 
individuals who attained their 100th year of life without 
the diagnosis of common age-associated illnesses. Cen-
tenarians have, therefore, shown successful ageing and 
have in some way developed an age-related robustness 
and resilience to disease. This resilience includes cancer, 
where proportional mortality rates increase with age dur-
ing most of adulthood but decline in advanced age from 
nearly 40 % of all deaths between the ages of 50 and 69 to 
only 4 % of all deaths in patients older than age 100 years 
[49]. These data suggest that the oldest-old humans have 
a cancer-resistant phenotype compared to the general 
population. In the current study, cancer was the cause of 
euthanasia in 54 % of the dogs that lived to an Expected 
age, 27 % in the Long group and 33 % in the Exceptional 
group, suggesting that the longer-living dogs may have 
been less likely to experience cancer although this was 
not statistically significant. We were not able to show 
any association of cause of death with lifespan group or 
gender although this is likely due to the small numbers of 
dogs in each group.
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Conclusions
The findings of this study indicate that the life-long main-
tenance of lean body mass and an attenuated accumulation 
of body fat are key factors influencing successful ageing 
as reflected by longer healthspan. In the current study, 
the combination of a high quality plane of nutrition with 
appropriate husbandry and veterinary care resulted in 28 % 
of the dogs reaching an Exceptional lifespan of ≥15.6 years 
and almost 90 % of the dogs exceeded the typical lifespan of 
12 years. Future work includes further analysis of the data 
from this 10+ year study using survival analysis and other 
techniques to look at how variables change over time. The 
long-term objective is to provide clear and practical recom-
mendations for both dog owners and veterinarians so that 
all dogs can live to their full genetic potential.
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